Broxaterol
From Wikipedia, the free encyclopedia
![]() |
This article needs more links to other articles to help integrate it into the encyclopedia. (May 2016) (Learn how and when to remove this template message) |
![]() |
|
Names | |
---|---|
IUPAC name
1-(3-Bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol
|
|
Identifiers | |
76596-57-1 ![]() |
|
3D model (Jmol) | Interactive image Interactive image Interactive image |
ChEMBL | ChEMBL2105475 ![]() |
ChemSpider | 64294 ![]() |
ECHA InfoCard | 100.071.338 |
MeSH | Broxaterol |
PubChem | 71149 |
UNII | ZE4IRB4DUC ![]() |
|
|
|
|
Properties | |
C9H15BrN2O2 | |
Molar mass | 263.14 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Broxaterol is a β2 adrenoreceptor agonist.[1]
References[edit]
- ^ Nava S, Crotti P, Gurrieri G, Fracchia C, Rampulla C (January 1992). "Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction". Chest. 101 (1): 133–40. doi:10.1378/chest.101.1.133. PMID 1345900.
![]() |
This article about an organic compound is a stub. You can help Wikipedia by expanding it. |
![]() |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |